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We describe the mechanisms underlying the vascular contraction
induced by succinate. The data presented here are related to the article
entitled “Pharmacological characterization of the mechanisms under-
lying the vascular effects of succinate” (L.N. Leite, N.A. Gonzaga, J.A.
Simplicio, G.T. Vale, J.M. Carballido, J.C. Alves-Filho, C.R. Tirapelli, 2016)
[1]. Succinate acts as a signaling molecule by binding to a G-protein-
coupled receptor termed GPR91, “Citric acid cycle intermediates as
ligands for orphan G-protein-coupled receptors” (W. He, F.J. Miao, D.C.
Lin, R.T. Schwandner, Z. Wang, J. Gao, J.L. Chen, H. Tian, L. Ling, 2004)
[2]. Here we include data on the contractile effect of succinate in the
aorta. Succinate contracted both endothelium-intact and endothelium-
denuded aortic rings isolated from male Wistar rats or C57BL/6 mice.
Succinate was less effective at inducing contraction in arteries isolated
from GPR91-deﬁcient mice, when compared to its vascular effect in
aortas from wild type mice. SB203508 (p38MAK inhibitor), SP600125
(JNK inhibitor) and Y27632 (Rho-kinase inhibitor) reduced succinate-
induced contraction in both endothelium-intact and endothelium-
denuded rat aortic rings, while PD98059 (ERK1/2 inhibitor) did not
affect succinate-induced contraction. The contractile response inducedvier Inc. This is an open access article under the CC BY license
/j.ejphar.2016.07.045
, Escola de Enfermagem de Ribeirão Preto, Avenida Bandeirantes 3900, CEP
315 3271.
apelli).
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aortic rings was reduced by indomethacin (non-selective cycloox-
ygenase inhibitor), H7 (protein kinase C inhibitor), verapamil (Ca2þ
channel blocker) and tiron (superoxide anion scavenger).
& 2016 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc sub-
ject areaVascular Pharmacologyype of data Graph
ow data was
acquiredIsometric force transducer (TRI201; Panlab, Spain)ata format Analyzed
xperimental
factorsThe thoracic aorta was isolated from male Wistar rats or C57BL/6 mice, cut
into rings (4 mm in length) and maintained in organ chambersxperimental
featuresInhibitors of distinct pathways were used to determine the mechanisms
underlying succninate-induced contractionata source location Ribeirao Preto, Brazil
ata accessibility Data are within this articleD
Value of the data
 Succinate displays a direct contractile effect on the vasculature.
 The contraction induced by succinate is partially mediated by GPR91 receptors.
 The data provide insights into the mechanisms underlying the contractile effect of succinate.1. Data
Data describes the contractile action of succninate. Fig. 1 shows representative traces of the
contractile effect of succinate on endothelium-intact and endothelium-denuded aortic rings from
Wistar rats and C57BL/6 or GPR91 / mice. The maximal contraction induced by succinate in
endothelium-intact and endothelium-denuded aortas isolated from Wistar rats and C57BL/6 or
GPR91-deﬁcient mice are represented on Fig. 2.
The effects of SB203508, SP600125, PD98059 and Y27632 on succinate-induced contraction are
represented on Fig. 3. The contractile response induced by succinate on endothelium-intact and
endothelium-denuded rat aortic rings was reduced by indomethacin, H7, verapamil and tiron (Fig. 4).2. Experimental design, materials and methods
Male Wistar rats (230–250 g) and C57BL/6 or GPR91 / mice (20–25 g) were anaesthetized
intraperitoneally with urethane at 1.25 g/kg (Sigma-Aldrich, St. Louis, MO, USA) and the thoracic aorta
was mounted in organ chambers [1]. The contraction induced by succinate (50–130 mmol/L) was
evaluated in endothelium-intact and endothelium-denuded rat aortic rings. In another set of
experiments, the contractile effect of succinate (0.03–130 mmol/L) was evaluated in endothelium-
intact and endothelium-denuded aortic rings from C57BL/6 and GPR91/ mice [2].
Succinate (50-130 mmol/l) Succinate (50-130 mmol/l)
5 mN
5 min
Succinate (0.03-130 mmol/l) Succinate (0.03-130 mmol/l)
1.5 mN
2 min
Succinate (0.03-130 mmol/l) Succinate (0.03-130 mmol/l)
1.5 mN
2 min
Rat (Endo+) Rat (Endo-)
C57BL/6 (Endo+) C57BL/6 (Endo-)
GPR91-/- (Endo+) GPR91-/- (Endo-)
Fig. 1. Original traces showing the contractile effect of succinate. The contraction induced by succinate was obtained in
endothelium-intact (Endoþ) and endothelium-denuded (Endo) aortic rings isolated from Wistar rats and C57BL/6 or
GPR91 / mice.
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endothelium-intact or endothelium-denuded rat aortic rings incubated for 30 min with one of the
following drugs: SB203508 (10 mmol/L, p38MAK inhibitor), SP600125 (10 mmol/L, JNK inhibitor),
PD98059 (10 mmol/L, ERK1/2 inhibitor), Y27632 (10 mmol/L, Rho-kinase inhibitor), H7 (10 μmol/L,
protein kinase C inhibitor), indomethacin (10 μmol/L, non-selective cyclooxygenase inhibitor), tiron
(superoxide anion scavenger, 100 μmol/L) or verapamil (1 μmol/L, Ca2þ channel blocker).
Results are expressed as means7standard errors of the mean (S.E.M.). Statistical analysis was
performed using one-way analysis of variance (ANOVA) followed by Newman–Keuls multiple com-
parison test. P values of less than 0.05 were considered signiﬁcant.
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Fig. 2. Contractile responses induced by succinate on rat and mouse aortic rings. The contraction induced by succinate was
studied on endothelium-intact (Endoþ) and endothelium-denuded (Endo) aortic rings from Wistar rats (A) and C57BL/6 or
GPR91 / mice (B and C). Results are presented as means7S.E.M. of 7 to 9 experiments. *Compared to C57BL/6;**Compared to
Endoþ (Po0.05, ANOVA followed by Newman–Keuls multiple comparison test).
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Fig. 3. Effect of SB203508, SP600125, PD98059 and Y27632 on succinate-induced contractile response in endothelium-intact
(left) and endothelium-denuded (right) rat aortic rings. The contractile response induced by succinate was determined before
(control) or after incubation for 30 min with SB203508 (10 mmol/L), SP600125 (10 mmol/L), PD98059 (10 mmol/L) or Y27632
(10 mmol/L). Results are presented as means7S.E.M. of 6 to 10 experiments. *Compared to respective control group (Po0.05,
ANOVA followed by Newman–Keuls multiple comparison test).
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Fig. 4. Effect of indomethacin, H7, tiron and verapamil on succinate-induced contractile response in endothelium-intact and
denuded rat aortic rings. The contractile response induced by succinate was determined before (control) or after incubation for
30 min with indomethacin (10 mmol/L), H7 (10 mmol/L), verapamil (1 mmol/L) or tiron (100 mmol/L). Results are presented as
means7S.E.M. of 6 to 10 experiments. *Compared to respective control group (Po0.05, ANOVA followed by Newman–Keuls
multiple comparison test).
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